Najnowsze artykuły:
Moderna's combination skin cancer therapy receives FDA's breakthrough tag By Reuters - Investing.com
Moderna's combination skin cancer therapy receives FDA's breakthrough tag ...
The spray is one of several needle-free devices being developed to treat between 33 million and 45 million Americans with severe allergies to food and other triggers Titanium dioxide, a colouring ...
BRISBANE, Calif. - Vera Therapeutics, Inc. (NASDAQ:VERA), a biotech firm specializing in immunological disease treatments, announced today that the FDA has granted Breakthrough Therapy Designation ...
Elon Musk's Neuralink has been granted the FDA's breakthrough device designation for its vision implant, Blindsight. This technology aims to restore sight for those who have lost it or were born ...
uniQure (QURE) stock surges 39% as FDA grants Breakthrough Therapy designation for AMT-130, a gene therapy for Huntington’s disease. Read more here.
Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication for individuals with severe speech impairment, Elon Musk's brain implant ...
The FDA's Breakthrough Devices Program is designed to expedite the development, assessment, and review of medical devices that can provide significant improvements over current treatment options.
The FDA sent a warning letter to Amazon over the sale of mole and skin tag removal products. The agency says there are not any authorized over-the-counter mole removers.
Pyxis Oncology (PYXS) stock rises as the FDA issues fast track designation for its lead asset PYX-201 in head and neck cancer. Read more here.
The FDA has committed to training Fidelity Bank staff and SME beneficiaries on regulatory requirements, championing best practices, safeguarding application submissions, ...
Fresenius lands FDA Class I tag for recall of dialysis machines that may expose patients to toxic chemicals By Andrea Park Oct 25, 2023 10:15am ...
Vera Therapeutics, Inc. (NASDAQ:VERA) has been a company of interest for investors following its recent FDA Breakthrough Therapy Designation. With a market capitalization of approximately $2.03 ...